| Dharmendra Verma, MD | |
|
1259 Fm 1463 Rd Ste 500, Katy, TX 77494-5480 | |
| (832) 443-3725 | |
| Not Available |
| Full Name | Dharmendra Verma |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 24 Years |
| Location | 1259 Fm 1463 Rd Ste 500, Katy, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225142623 | NPI | - | NPPES |
| 183318801 | Medicaid | TX | |
| 8S0021 | Other | TX | BCBS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jackson Healthcare Center | Edna, TX | Hospital |
| Citizens Medical Center | Victoria, TX | Hospital |
| Cuero Regional Hospital | Cuero, TX | Hospital |
| De Tar Hospital Navarro | Victoria, TX | Hospital |
| Refugio County Memorial Hospital | Refugio, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Health And Wellness Solutions Pa | 3173704053 | 6 |
| Ut Physicians | 8426960360 | 1400 |
News Archive
Of the 4 million prisoners released each year, 23 percent have suffered from major depressive disorder. Due to resource shortages, many go without adequate treatment while in prison. Oftentimes they rejoin society in worse mental shape than before their incarceration - which could be prevented with the right care.
Magnolias are prized for their large, colorful, fragrant flowers. Does the attractive, showy tree also harbor a potent cancer fighter?
Penn Medicine will establish the Philadelphia region's first dedicated center for the treatment and research of blood diseases by combining the expertise of physicians who specialize in the care of blood disorder patients of all ages along with basic science and clinical researchers who are working to advance treatments for these illnesses.
Synta Pharmaceuticals Corp. today announced the initiation of three multicenter, randomized trials supported by the Leukemia & Lymphoma Research Fund and Cancer Research UK, evaluating ganetespib in combination with chemotherapy in first-line treatment of patients with AML and high risk MDS.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
› Verified 9 days ago
| Entity Name | Ut Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033157821 PECOS PAC ID: 8426960360 Enrollment ID: O20031107000268 |
News Archive
Of the 4 million prisoners released each year, 23 percent have suffered from major depressive disorder. Due to resource shortages, many go without adequate treatment while in prison. Oftentimes they rejoin society in worse mental shape than before their incarceration - which could be prevented with the right care.
Magnolias are prized for their large, colorful, fragrant flowers. Does the attractive, showy tree also harbor a potent cancer fighter?
Penn Medicine will establish the Philadelphia region's first dedicated center for the treatment and research of blood diseases by combining the expertise of physicians who specialize in the care of blood disorder patients of all ages along with basic science and clinical researchers who are working to advance treatments for these illnesses.
Synta Pharmaceuticals Corp. today announced the initiation of three multicenter, randomized trials supported by the Leukemia & Lymphoma Research Fund and Cancer Research UK, evaluating ganetespib in combination with chemotherapy in first-line treatment of patients with AML and high risk MDS.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
› Verified 9 days ago
| Entity Name | Health And Wellness Solutions Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922302124 PECOS PAC ID: 3173704053 Enrollment ID: O20110225000035 |
News Archive
Of the 4 million prisoners released each year, 23 percent have suffered from major depressive disorder. Due to resource shortages, many go without adequate treatment while in prison. Oftentimes they rejoin society in worse mental shape than before their incarceration - which could be prevented with the right care.
Magnolias are prized for their large, colorful, fragrant flowers. Does the attractive, showy tree also harbor a potent cancer fighter?
Penn Medicine will establish the Philadelphia region's first dedicated center for the treatment and research of blood diseases by combining the expertise of physicians who specialize in the care of blood disorder patients of all ages along with basic science and clinical researchers who are working to advance treatments for these illnesses.
Synta Pharmaceuticals Corp. today announced the initiation of three multicenter, randomized trials supported by the Leukemia & Lymphoma Research Fund and Cancer Research UK, evaluating ganetespib in combination with chemotherapy in first-line treatment of patients with AML and high risk MDS.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dharmendra Verma, MD 8806 N Navarro St Ste 600, Victoria, TX 77904-1564 Ph: (361) 485-2695 | Dharmendra Verma, MD 1259 Fm 1463 Rd Ste 500, Katy, TX 77494-5480 Ph: (832) 443-3725 |
News Archive
Of the 4 million prisoners released each year, 23 percent have suffered from major depressive disorder. Due to resource shortages, many go without adequate treatment while in prison. Oftentimes they rejoin society in worse mental shape than before their incarceration - which could be prevented with the right care.
Magnolias are prized for their large, colorful, fragrant flowers. Does the attractive, showy tree also harbor a potent cancer fighter?
Penn Medicine will establish the Philadelphia region's first dedicated center for the treatment and research of blood diseases by combining the expertise of physicians who specialize in the care of blood disorder patients of all ages along with basic science and clinical researchers who are working to advance treatments for these illnesses.
Synta Pharmaceuticals Corp. today announced the initiation of three multicenter, randomized trials supported by the Leukemia & Lymphoma Research Fund and Cancer Research UK, evaluating ganetespib in combination with chemotherapy in first-line treatment of patients with AML and high risk MDS.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
› Verified 9 days ago
Yumna Ghouri, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 23900 Katy Fwy, Katy, TX 77494 Phone: 281-644-8111 Fax: 281-644-8144 | |
Dr. Shazia F Sheikh, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 23211 Red River Dr, Katy, TX 77494 Phone: 832-437-2427 Fax: 281-396-4798 | |
Dr. Gurjyot Kaur Doshi, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1331 W Grand Pkwy N, Suite 340, Katy, TX 77493 Phone: 281-392-2757 Fax: 281-392-8148 | |
Alvin Raymond Co Tan, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2510 W Grand Pkwy N, Katy, TX 77449 Phone: 713-442-4222 | |
William Alexander Currie, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 21700 Kingsland Blvd, Suite 201, Katy, TX 77450 Phone: 281-398-7954 Fax: 281-398-6320 | |
Ebba M Tsinopoulos, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 21720 Kingsland Blvd, Katy, TX 77450 Phone: 212-409-6121 Fax: 405-745-9602 | |
Jennifer Leigh Thomas, NP Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 20710 Westheimer Pkwy, Katy, TX 77450 Phone: 936-277-1000 Fax: 936-994-9020 |